Biomarkers Predict In-Hospital Major Adverse Cardiac Events in COVID-19 Patients: A Multicenter International Study.
Michael Y HeneinGiulia Elena MandoliMaria Concetta PastoreNicolò GhionzoliFouhad HassonMuhammad K NisarMohammed IslamFrancesco BanderaMassimiliano M Marrocco-TrischittaIrene BaroniAlberto Maria LanzoneLuca RossiAndrea BiagiRodolfo CitroMichele CiccarelliAngelo SilverioGiulia BiagioniJoseph A MoutirisFederico VancheriGiovanni MazzolaGiulio GeraciLiza ThomasMikhail AltmanJohn PernowMona AhmedCiro SantoroRoberta EspositoGuillem CasasRubén Fernández-GaleraMaribel GonzalezJose Rodriguez PalomaresIbadete BytyciFrank Lloyd DiniPaolo CameliFederico FranchiGani BajraktariLuigi Paolo BadanoMatteo CameliPublished in: Journal of clinical medicine (2021)
Our findings, derived from a multicenter data collection study, suggest the routine use of biomarkers, such as cardiac troponin and serum creatinine, for in-hospital prediction of CV events in patients with COVID-19.